NCT00094666终止3 期
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Elderly Patients With Primary Insomnia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 465
- 主要终点
- Amount of time spent awake and time to fall asleep at night after two days
研究概览
简要总结
The purpose of the study is to test the safety and effectiveness of an Investigational Drug on insomnia in the elderly.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Elderly patients with a diagnosis of primary insomnia and in good physical and mental health
排除标准
- 未提供
结局指标
主要结局
Amount of time spent awake and time to fall asleep at night after two days
次要结局
- Amount of time spent awake and time to fall asleep at night after 30 days
- Amount of deep sleep after two days
研究者
相似试验
已完成
3 期
Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)Primary InsomniaNCT00094627H. Lundbeck A/S465
撤回
3 期
An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)InsomniaNCT00102154H. Lundbeck A/S
已完成
2 期
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)Alzheimer's DiseaseNCT00420420Merck Sharp & Dohme LLC144
已完成
2 期
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic PainPainDiabetic NeuropathiesNCT00375960Vernalis (R&D) Ltd50
已完成
2 期
Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.AsthmaNCT00600171GlaxoSmithKline614